Journal article
Dr. Roberts and colleagues reply
AW Roberts, MS Davids, JF Seymour
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2016
DOI: 10.1056/NEJMc1602674
Abstract
To the Editor: Roberts et al. (Jan. 28 issue)1 describe improved outcomes for patients with relapsed chronic lymphocytic leukemia (CLL) who were treated with venetoclax, a drug that targets BCL2 pr...